In summary, the USMCA contains many provisions that advance public health and FDA regulatory approaches. Now that the agreement has come into effect, we will continue to follow what it means for the FDA, for public health and for our regulated industries. Economists David Autor, David Dorn and Gordon Hanson weigh the impact of trade with China and Mexico on the U.S. labour market in this 2016 paper [PDF] for the National Bureau of Economic Research. The agreement is designated differently by each signatory – in the United States, it is called the U.S.-Mexico-Canada Agreement (USMCA);   in Canada, it is officially known as the Canada-U.S.-Mexico Agreement (CUSMA) in English and the Canada-U.S.-Mexico Agreement (ACEUM) in French;  and in Mexico, tratado is called tratado between México, Estados Unidos y Canadé (T-MEC).   The agreement is sometimes referred to as “New NAFTA” with respect to the previous trilateral agreement for the successor, the North American Free Trade Agreement (NAFTA). The second parallel agreement is the North American Environmental Cooperation Agreement (NAAEC), which established the Commission for Environmental Cooperation (CEC) in 1994. The CEC is responsible for strengthening regional cooperation in the environmental field, reducing potential trade and environmental conflicts and promoting effective enforcement of environmental legislation. It also facilitates public cooperation and participation in efforts to promote conservation, protection and improvement of the North American environment. It consists of three main components: the Council (Minister of the Environment), the Joint Advisory Committee of Governments (JPAC) and the Secretariat, which is headquartered in Montreal. It has an annual budget of $9 million, with Canada, Mexico and the United States contributing $3 million per year and settled by consensus (non-majority). The USMCA establishes the highest level of a U.S. trade agreement for strong and effective protection and enforcement of intellectual property rights.
This is a significant enhancement of NAFTA. Nevertheless, in December 2019, following negotiations on the revision of the USMCA text signed in November 2018, substantial changes were made to Chapter 20 of intellectual property. The FDA was an important member of the U.S. team that negotiated the U.S.-Mexico-Canada Agreement (USMCA), which came into effect on July 1 of this year. From the FDA`s perspective, the agreement adapts regulatory standards to public administration practices, improves the quality of products available to U.S. consumers and a level playing field for U.S. companies. Canada and the United States have also agreed on strict rules to ensure fair and transparent management of tariff quotas to ensure that distributors can use them fully. On April 24, 2020, U.S. Trade Representative Robert Lighthizer formally announced to Congress that the new trade agreement is expected to come into effect on July 1, 2020, and he also informed Canada and Mexico.   During the 2016 U.S.
presidential election, Donald Trump`s campaign included a promise to renegotiate or eliminate NAFTA if the renegotiations failed.  After the election, Trump made a series of changes that influenced trade relations with other countries. The exit from the Paris Agreement, the cessation of participation in the Trans-Pacific Partnership negotiations and the significantly larger increase in tariffs with China were some of the steps he took, which reinforced the fact that he was serious about changing NAFTA.  Much of the debate about the virtues and errors of the USMCA resembles the debate on all free trade agreements (FTAs), such as the nature of free trade agreements as public goods, potential violations of national sovereignty and the role of commercial, labour, environmental and consumer interests in the development of the language of trade agreements.